NASDAQ: BPMCBlueprint Medicines Corp Stock Ownership - Who owns Blueprint Medicines?
Insider buying vs selling
Have Blueprint Medicines Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-28 | 5,000 | $36.05 | $180.25kBuy |
| Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-28 | 5,000 | $95.00 | $475.00kSell |
| Jeffrey W. Albers | Director | 2024-03-20 | 1,367 | $89.12 | $121.83kSell |
| Jeffrey W. Albers | Director | 2024-03-20 | 15,073 | $1.87 | $28.19kBuy |
| Jeffrey W. Albers | Director | 2024-03-20 | 10,000 | $15.01 | $150.10kBuy |
| Jeffrey W. Albers | Director | 2024-03-20 | 2,730 | $85.22 | $232.65kSell |
| Jeffrey W. Albers | Director | 2024-03-20 | 6,251 | $86.46 | $540.46kSell |
| Jeffrey W. Albers | Director | 2024-03-20 | 8,440 | $87.26 | $736.47kSell |
| Jeffrey W. Albers | Director | 2024-03-20 | 6,285 | $88.60 | $556.85kSell |
| Michael Landsittel | CHIEF FINANCIAL OFFICER | 2024-03-15 | 2,675 | $87.10 | $232.99kSell |
BPMC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BPMC insiders and whales buy or sell their stock.
BPMC Shareholders
What type of owners hold Blueprint Medicines Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.75% | 6,584,176 | $612.33M | Institution |
| Vanguard Group Inc | 9.99% | 6,114,970 | $568.69M | Institution |
| Kevin P. Starr | 8.91% | 5,453,753 | $507.20M | Insider |
| Price T Rowe Associates Inc | 8.87% | 5,428,955 | $504.89M | Institution |
| Fmr LLC | 7.10% | 4,348,311 | $404.39M | Institution |
| Wellington Management Group LLP | 6.98% | 4,276,333 | $397.70M | Institution |
| Fmr LLC | 6.63% | 4,062,040 | $377.77M | Insider |
| Mark J. Levin | 5.82% | 3,564,997 | $331.54M | Insider |
| Rock Springs Capital Management LP | 4.71% | 2,881,567 | $267.99M | Institution |
| State Street Corp | 3.96% | 2,424,200 | $225.45M | Institution |
BPMC vs Biotech Stocks
Blueprint Medicines Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.